Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 23, 2022 / 02:30PM GMT
Release Date Price: $283.57 (-2.08%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Great. Well, thanks for joining us here at the Citi Virtual Healthcare Conference. I'm Patrick Donnelly. I'm the tools, diagnostics and CRO analyst here at Citi. Excited to have Jim Foster, CEO of Charles River, here with us today. A very topical time in CRO land to discuss a bunch of different variables. (Operator Instructions)

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

But Jim, maybe we can just dive in, maybe not surprisingly, we can start on the funding environment. That's been the biggest question all week, even all year, but certainly has intensified in the last week or so. You guys put up good results. Obviously, you talked really bullishly about the bookings environment.

Maybe you can just talk about the biotech funding elephant in the room. Obviously, again, your commentary, your peers' commentary certainly seems positive outside of one obvious outlier, a kind of your smaller peer. Clearly, the funding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot